全文获取类型
收费全文 | 2367篇 |
免费 | 119篇 |
国内免费 | 14篇 |
专业分类
耳鼻咽喉 | 43篇 |
儿科学 | 86篇 |
妇产科学 | 39篇 |
基础医学 | 201篇 |
口腔科学 | 39篇 |
临床医学 | 184篇 |
内科学 | 555篇 |
皮肤病学 | 65篇 |
神经病学 | 199篇 |
特种医学 | 104篇 |
外科学 | 429篇 |
综合类 | 32篇 |
一般理论 | 3篇 |
预防医学 | 97篇 |
眼科学 | 69篇 |
药学 | 163篇 |
中国医学 | 5篇 |
肿瘤学 | 187篇 |
出版年
2024年 | 4篇 |
2023年 | 19篇 |
2022年 | 46篇 |
2021年 | 91篇 |
2020年 | 51篇 |
2019年 | 65篇 |
2018年 | 86篇 |
2017年 | 57篇 |
2016年 | 61篇 |
2015年 | 87篇 |
2014年 | 128篇 |
2013年 | 136篇 |
2012年 | 225篇 |
2011年 | 203篇 |
2010年 | 138篇 |
2009年 | 104篇 |
2008年 | 161篇 |
2007年 | 156篇 |
2006年 | 140篇 |
2005年 | 125篇 |
2004年 | 98篇 |
2003年 | 88篇 |
2002年 | 75篇 |
2001年 | 17篇 |
2000年 | 16篇 |
1999年 | 18篇 |
1998年 | 14篇 |
1997年 | 8篇 |
1996年 | 6篇 |
1995年 | 6篇 |
1994年 | 12篇 |
1993年 | 9篇 |
1992年 | 2篇 |
1991年 | 5篇 |
1990年 | 3篇 |
1989年 | 4篇 |
1988年 | 1篇 |
1987年 | 3篇 |
1986年 | 3篇 |
1985年 | 6篇 |
1984年 | 8篇 |
1983年 | 2篇 |
1982年 | 2篇 |
1981年 | 4篇 |
1980年 | 1篇 |
1979年 | 2篇 |
1978年 | 1篇 |
1976年 | 2篇 |
1939年 | 1篇 |
排序方式: 共有2500条查询结果,搜索用时 15 毫秒
21.
22.
23.
Pulmonary hypertension: Barrier or just a bump in the road in transplanting adults with congenital heart disease
下载免费PDF全文
![点击此处可从《Congenital heart disease》网站下载免费的PDF全文](/ch/ext_images/free.gif)
Jonathan N. Menachem MD Edo Y. Birati MD Payman Zamani MD Anjali T. Owens MD Pavan Atluri MD Christian A. Bermudez MD David Drajpuch NP Stephanie Fuller MD Yuli Y. Kim MD Christopher E. Mascio MD Vikram Palanivel MD J. Eduardo Rame MD Joyce Wald DO Michael A. Acker MD Jeremy A. Mazurek MD 《Congenital heart disease》2018,13(4):492-498
24.
25.
26.
27.
28.
Pharmacological characterization of ZYDPLA1, a novel long‐acting dipeptidyl peptidase‐4 inhibitor
下载免费PDF全文
![点击此处可从《Journal of Diabetes》网站下载免费的PDF全文](/ch/ext_images/free.gif)
29.
Vikram Kilambi F. Reed Johnson Juan Marcos González Ateesha F. Mohamed 《Value in health》2014,17(8):838-845
BackgroundThe value of the information that genetic testing services provide can be questioned for insurance-based health systems. The results of genetic tests oftentimes may not lead to well-defined clinical interventions; however, Lynch syndrome, a genetic mutation for which carriers are at an increased risk for colorectal cancer, can be identified through genetic testing, and meaningful health interventions are available via increased colonoscopic surveillance. Valuations of test information for such conditions ought to account for the full impact of interventions and contingent outcomes.ObjectivesTo conduct a discrete-choice experiment to elicit individuals’ preferences for genetic test information.MethodsA Web-enabled discrete-choice experiment survey was administered to a representative sample of US residents aged 50 years and older. In addition to specifying expenditures on colonoscopies, respondents were asked to make a series of nine selections between two hypothetical genetic tests or a no-test option under the premise that a relative had Lynch syndrome. The hypothetical genetic tests were defined by the probability of developing colorectal cancer, the probability of a false-negative test result, privacy of the result, and out-of-pocket cost. A model specification identifying necessary interactions was derived from assumptions of risk behavior and the decision context and was estimated using random-parameters logit.ResultsA total of 650 respondents were contacted, and 385 completed the survey. The monetary equivalent of test information was approximately $1800. Expenditures on colonoscopies to reduce mortality risks affected valuations. Respondents with lower income or who reported being employed significantly valued genetic tests more.ConclusionGenetic testing may confer benefits through the impact of subsequent interventions on private individuals. 相似文献
30.